Based on TCGA data, it was proven that, among mutated genes typical for CRC (e.g., APC, TP53, SMAD4, PIK3CA, and KRAS) [5,19,20], there were also copy-number changes including amplifications of ERBB2 and IGF2 [6,29]. This evidence concerns the gene IGF2 and colorectal carcinoma.